APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
47 hedge funds and large institutions have $13.4M invested in Aptose Biosciences, Inc. in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
47
Holding in Top 10
–
Calls
$32K
Puts
–
Top Buyers
| 1 | +$99.2K | |
| 2 | +$58K | |
| 3 | +$55.2K | |
| 4 |
AC
Annandale Capital
Dallas,
Texas
|
+$52.2K |
| 5 |
FAM
Formidable Asset Management
Cincinnati,
Ohio
|
+$52K |
Top Sellers
| 1 | -$485K | |
| 2 | -$370K | |
| 3 | -$336K | |
| 4 |
Morgan Stanley
New York
|
-$44.6K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$41K |